Yasuaki Oda
Overview
Explore the profile of Yasuaki Oda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu L, Yang J, Otani Y, Shiga T, Yamaguchi A, Oda Y, et al.
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139018
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode (MELAS) syndrome, caused by a single base substitution in mitochondrial DNA (m.3243A>G), is one of the most common maternally inherited mitochondrial diseases accompanied...
2.
Yang J, Liu L, Oda Y, Wada K, Ago M, Matsuda S, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373439
Mitochondria are essential organelles for maintaining intracellular homeostasis. Their dysfunction can directly or indirectly affect cell functioning and is linked to multiple diseases. Donation of exogenous mitochondria is potentially a...
3.
Yang J, Liu L, Oda Y, Wada K, Ago M, Matsuda S, et al.
Stem Cell Res Ther
. 2023 Mar;
14(1):40.
PMID: 36927781
Background: Mitochondrial dysfunction caused by mutations in mitochondrial DNA (mtDNA) or nuclear DNA, which codes for mitochondrial components, are known to be associated with various genetic and congenital disorders. These...
4.
Ohnishi H, Oda Y, Ohgushi H
Sci Technol Adv Mater
. 2016 Nov;
11(1):014110.
PMID: 27877325
Mesenchymal stem cells (MSCs) are adult stem cells which show differentiation capabilities toward various cell lineages. We have already used MSCs for treatments of osteoarthritis, bone necrosis and bone tumor....
5.
Taketani T, Oyama C, Mihara A, Tanabe Y, Abe M, Hirade T, et al.
Cell Transplant
. 2014 Nov;
24(10):1931-43.
PMID: 25396326
Patients with severe hypophosphatasia (HPP) develop osteogenic impairment with extremely low alkaline phosphatase (ALP) activity, resulting in a fatal course during infancy. Mesenchymal stem cells (MSCs) differentiate into various mesenchymal...
6.
Ohnishi H, Oda Y, Aoki T, Tadokoro M, Katsube Y, Ohgushi H, et al.
J Tissue Eng Regen Med
. 2011 Jun;
6(4):261-71.
PMID: 21706774
Bone marrow-derived mesenchymal stem cells (BMSCs) and adipose tissue-derived mesenchymal stem cells (AMSCs) have been used clinically for tissue regeneration; however, their proliferation/differentiation potentials are limited. Recently, induced pluripotent stem...
7.
Oda Y, Yoshimura Y, Ohnishi H, Tadokoro M, Katsube Y, Sasao M, et al.
J Biol Chem
. 2010 Jul;
285(38):29270-8.
PMID: 20595386
The expression of four transcription factors (OCT3/4, SOX2, KLF4, and MYC) can reprogram mouse as well as human somatic cells to induced pluripotent stem (iPS) cells. We generated iPS cells...
8.
Aoki T, Ohnishi H, Oda Y, Tadokoro M, Sasao M, Kato H, et al.
Tissue Eng Part A
. 2010 Feb;
16(7):2197-206.
PMID: 20146561
Human adipose-derived stem cells (hASCs) are ubiquitous, plentiful, and easily/safely obtainable cells derived from adipose tissue, regardless of the age and sex of the donor. However, the hASCs have limited...
9.
Takahashi K, Maruyama M, Tokuzawa Y, Murakami M, Oda Y, Yoshikane N, et al.
Genomics
. 2005 Feb;
85(3):360-71.
PMID: 15718103
Only a few cases of exclusive translation initiation at non-AUG codons have been reported. We recently demonstrated that mammalian NAT1 mRNA, encoded by EIF4G2, uses GUG as its only translation...